Direct-to-consumer advertising of psychiatric medications appears to increase prescribing, which may be having a mixed effect on the quality of treatment, according to a new review of the very few studies on the topic.
Direct-to-consumer advertising of psychiatric medications appears to increase prescribing, which may be having a mixed effect on the quality of treatment, according to a new review of the very few studies on the topic.